Marc Engelhardt is Chief Medical Officer at Basilea Pharmaceutica AG.

In the past Dr. Engelhardt was Director-Global Program Medical at Novartis Pharma AG.

Dr. Engelhardt received an undergraduate degree and a doctorate from Johann Wolfgang Goethe-Universität Frankfurt am Main.